Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
- PMID: 36065312
- PMCID: PMC9440776
- DOI: 10.1155/2022/5227771
Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
Abstract
Background: Esophageal squamous cell carcinoma (ESCC) is a common second primary neoplasia in patients with a history of head and neck squamous cell carcinoma (HNSCC). The aim of this study was to provide further information and novel insights into the risk factors for ESCC in patients with HNSCC.
Methods: We retrospectively analyzed 98 HNSCC patients diagnosed from 2007 to 2017, 30 HNSCC patients suffering from ESCC, who had undergone endoscopic examination because of positive imaging examinations or symptoms, and 68 HNSCC patients who had no ESCC occurrence for at least six years post-HNSCC diagnosis. Associated clinicopathological data and lifestyle information of the ESCC group and the without ESCC group were collected, and a case-control study of risk factors was analyzed between the two groups.
Results: The majority (83.4%) of the cases with HNSCC esophageal cancers were male patients over 50 years. We established that 93.75% (30/32) of the ESCC occurred within six years after HNSCC diagnosis. HNSCC location, stage, and radiotherapy history had no significant association with the development of ESCC. High Ki67 labeling index (Ki67 LI) (>46) patients tended to be 3.1 times (95% CI = 1.3-7.6) more likely to develop ESCC compared to low Ki67 LI (≤45) patients (P < 0.05). Drinkers with alcohol flushing response were at a 3.3 times higher risk to have ESCC (95% CI = 1.0-10.4) than drinkers without flush response (P < 0.05).
Conclusions: HNSCC patients, especially drinkers with an alcohol flushing response, as well as those with high Ki67 LI of HNSCC tissue, were more likely to develop ESCC.
Copyright © 2022 Lei Wang et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures

Similar articles
-
Association of esophageal squamous cell carcinoma with head and neck cancer.Gastroenterol Hepatol. 2025 May;48(5):502318. doi: 10.1016/j.gastrohep.2024.502318. Epub 2024 Dec 9. Gastroenterol Hepatol. 2025. PMID: 39662764 English, Spanish.
-
Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors, and outcomes.Int J Cancer. 2017 Nov 15;141(10):1987-1996. doi: 10.1002/ijc.30911. Epub 2017 Aug 9. Int J Cancer. 2017. PMID: 28758200
-
The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.Oral Oncol. 2020 Dec;111:104945. doi: 10.1016/j.oraloncology.2020.104945. Epub 2020 Aug 5. Oral Oncol. 2020. PMID: 32769036
-
Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck.Front Med (Lausanne). 2022 Apr 29;9:827297. doi: 10.3389/fmed.2022.827297. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572996 Free PMC article. Review.
-
Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention.Int J Clin Oncol. 2010 Apr;15(2):126-34. doi: 10.1007/s10147-010-0056-7. Epub 2010 Mar 12. Int J Clin Oncol. 2010. PMID: 20224884 Review.
Cited by
-
Locally advanced and metastatic esophageal squamous cell carcinoma in Morocco: from diagnosis to treatment.Ecancermedicalscience. 2025 Apr 1;19:1882. doi: 10.3332/ecancer.2025.1882. eCollection 2025. Ecancermedicalscience. 2025. PMID: 40503245 Free PMC article.
References
-
- Bugter O., van de Ven S. E. M., Hardillo J. A., Bruno M. J., Koch A. D., Baatenburg de Jong R. J. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: a systematic review and meta-analysis. Head & Neck . 2019;41(4):1122–1130. doi: 10.1002/hed.25548. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources